• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素难治性前列腺癌患者的躯体变化应对

Living with bodily changes in hormone-refractory prostate cancer.

机构信息

Research and Development Unit in Palliative Care, Stockholms Sjukhem Foundation, Stockholm, Sweden.

出版信息

Semin Oncol Nurs. 2011 Nov;27(4):309-16. doi: 10.1016/j.soncn.2011.07.009.

DOI:10.1016/j.soncn.2011.07.009
PMID:22018410
Abstract

OBJECTIVES

To review the current knowledge on living with bodily changes in hormone refractory prostate cancer (HRPC), treatment options, and common symptoms, and suggestions for improving our understanding of the experience of HRPC.

DATA SOURCE

Existing literature, research, and clinical experience.

CONCLUSION

Alleviation of bodily problems and providing care for men with HRPC is of utmost importance. It is important to talk about their situation and everyday life before asking about expected changes and problems related to the disease and its treatments.

IMPLICATIONS FOR NURSING PRACTICE

A preliminary framework is suggested for understanding the experience of HRPC from a nursing perspective. These results support an existing body of knowledge emphasizing the paramount importance of symptom alleviation, but indicate another motivation, that of freeing time, when time is so limited. The importance of dialogue between patients and health care providers is highlighted.

摘要

目的

回顾目前关于激素难治性前列腺癌(HRPC)患者身体变化、治疗选择和常见症状的知识,以及改善对 HRPC 患者体验的理解的建议。

资料来源

现有文献、研究和临床经验。

结论

缓解身体问题和为 HRPC 患者提供护理至关重要。在询问与疾病及其治疗相关的预期变化和问题之前,重要的是要谈论他们的情况和日常生活。

对护理实践的意义

从护理角度提出了一个理解 HRPC 体验的初步框架。这些结果支持了一个现有的知识体系,强调缓解症状的至关重要性,但也表明了另一个动机,即当时间如此有限时,腾出时间的重要性。突出了患者和医疗保健提供者之间对话的重要性。

相似文献

1
Living with bodily changes in hormone-refractory prostate cancer.激素难治性前列腺癌患者的躯体变化应对
Semin Oncol Nurs. 2011 Nov;27(4):309-16. doi: 10.1016/j.soncn.2011.07.009.
2
Dealing with a troublesome body: a qualitative interview study of men's experiences living with prostate cancer treated with endocrine therapy.应对身体的困扰:一项针对接受内分泌治疗的前列腺癌男性患者生活体验的定性访谈研究。
Eur J Oncol Nurs. 2012 Apr;16(2):103-8. doi: 10.1016/j.ejon.2011.04.005. Epub 2011 May 7.
3
Prostate-specific antigen doubling time is associated with survival in men with hormone-refractory prostate cancer.前列腺特异性抗原倍增时间与激素难治性前列腺癌男性患者的生存率相关。
Urology. 2006 Sep;68(3):565-9. doi: 10.1016/j.urology.2006.03.055.
4
Time and bodily changes in advanced prostate cancer: talk about time as death approaches.晚期前列腺癌中的时间与身体变化:谈谈死亡临近时的时间。
J Pain Symptom Manage. 2008 Dec;36(6):648-56. doi: 10.1016/j.jpainsymman.2007.12.013. Epub 2008 May 27.
5
Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer.构建转移性激素难治性前列腺癌患者报告结局的概念框架。
Value Health. 2010 Aug;13(5):613-23. doi: 10.1111/j.1524-4733.2010.00702.x. Epub 2010 Mar 10.
6
Management of the spectrum of hormone refractory prostate cancer.激素难治性前列腺癌谱系的管理
Eur Urol. 2006 Sep;50(3):428-38; discussion 438-9. doi: 10.1016/j.eururo.2006.05.017. Epub 2006 Jun 2.
7
Prednisone monotherapy in asymptomatic hormone refractory prostate cancer.无症状激素难治性前列腺癌的泼尼松单药治疗
Can J Urol. 2006 Dec;13(6):3335-9.
8
Second-line chemotherapy for advanced hormone-refractory prostate cancer.晚期激素难治性前列腺癌的二线化疗
Clin Adv Hematol Oncol. 2008 Feb;6(2):118-22, 127-32.
9
Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.激素难治性前列腺癌(HRPC):当前及未来的治疗方法
Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):11-34.
10
Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.接受雄激素剥夺疗法作为局限性或晚期前列腺癌主要或挽救性治疗的男性患者的生存结果:20年单中心经验
BJU Int. 2009 Nov;104(9):1208-14. doi: 10.1111/j.1464-410X.2009.08593.x. Epub 2009 Apr 17.

引用本文的文献

1
Translation and cultural adaptation of the Integrated Palliative care Outcome Scale including cognitive interviewing with patients and staff.整体舒缓治疗结局量表的翻译与文化调适:包括对患者和工作人员的认知访谈。
BMC Palliat Care. 2017 Sep 11;16(1):49. doi: 10.1186/s12904-017-0232-x.